4
Changes in Ownership
Edwards Lifesciences Corp Filed Acc 0001225208-23-008219
Global President TAVR & Surg sold 6,421 shares at $79.30 ($509,185)
- Global President TAVR & Surg acquired 6,421 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Wood Larry L · Global President TAVR & Surg
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-08-14 | Exercise or conversion : show line 1 in the form 10b5-1 | +6,421 | $45.28 | $290,722 | 220,214.71 | D |
| 2023-08-14 | Sale : show line 2 in the form 10b5-1 | −6,421 | $79.30 | $509,185 | 213,793.71 | D |
| Open-market sales · 6,421 sh · avg $79.30 · $509,185 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2023-08-14 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) | −6,421 | $45.28 | 2025-05-16 | 6,421 | 34,638 | D |
Loading xslF345X05/doc4.xml…